Randomized Trial of Osilodrostat for the Treatment of Cushing Disease

CONTEXT: Cushing disease, a chronic hypercortisolism disorder, is associated with considerable morbidity and mortality. Normalizing cortisol production is the primary treatment goal. OBJECTIVE: We aimed to evaluate the safety and efficacy of osilodrostat, a potent, orally available 11βhydroxylase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Mônica, Bex, Marie, Feelders, Richard A, Heaney, Anthony P, Auchus, Richard J, Gilis-Januszewska, Aleksandra, Witek, Przemyslaw, Belaya, Zhanna, Yu, Yerong, Liao, Zhihong, Ku, Chih Hao Chen, Carvalho, Davide, Roughton, Michael, Wojna, Judi, Pedroncelli, Alberto M, Snyder, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202723/
https://www.ncbi.nlm.nih.gov/pubmed/35325149
http://dx.doi.org/10.1210/clinem/dgac178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202723/
https://www.ncbi.nlm.nih.gov/pubmed/35325149
http://dx.doi.org/10.1210/clinem/dgac178

Ejemplares similares